NantHealth, Inc.
NHIQ
$0.05
$0.0494,900.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -19.63% | -23.27% | -8.96% | -16.34% | 4.59% |
| Total Depreciation and Amortization | 53.14% | -3.78% | -2.70% | 0.26% | 0.92% |
| Total Amortization of Deferred Charges | -13.64% | -13.00% | -9.15% | -2.11% | -15.62% |
| Total Other Non-Cash Items | 156,355.56% | 24,938.89% | -42.34% | 7.32% | -99.94% |
| Change in Net Operating Assets | -11.43% | 134.79% | 114.10% | 62.02% | 87.68% |
| Cash from Operations | 9.44% | 19.83% | 4.33% | -16.52% | -31.25% |
| Capital Expenditure | 14.53% | -2.75% | -26.99% | -27.36% | 7.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 14.53% | 6.64% | -14.60% | -14.80% | 15.54% |
| Total Debt Issued | 1,921.73% | 1,412.78% | -74.86% | -90.95% | -98.81% |
| Total Debt Repaid | 90.41% | 86.03% | 98.33% | 98.10% | 87.01% |
| Issuance of Common Stock | 5,539.10% | -100.00% | -100.00% | -91.75% | -26.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2,420.00% | -83.93% | -- | 100.00% |
| Cash from Financing | 488.53% | 436.85% | -19.65% | -73.38% | -119.65% |
| Foreign Exchange rate Adjustments | -1,566.10% | -515.96% | -298.33% | 927.27% | 172.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.55% | 100.99% | -145.94% | -484.57% | -320.93% |